Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Other Operating Expenses: 2019-2024

Historic Other Operating Expenses for Whitehawk Therapeutics (WHWK) over the last 5 years, with Dec 2024 value amounting to $3.0 million.

  • Whitehawk Therapeutics' Other Operating Expenses fell 122.01% to -$177,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $88.9 million, marking a year-over-year increase of 2711.14%. This contributed to the annual value of $3.0 million for FY2024, which is 7.65% up from last year.
  • As of FY2024, Whitehawk Therapeutics' Other Operating Expenses stood at $3.0 million, which was up 7.65% from $2.8 million recorded in FY2023.
  • Whitehawk Therapeutics' 5-year Other Operating Expenses high stood at $74.2 million for FY2021, and its period low was $2.8 million during FY2023.
  • In the last 3 years, Whitehawk Therapeutics' Other Operating Expenses had a median value of $3.0 million in 2024 and averaged $3.6 million.
  • As far as peak fluctuations go, Whitehawk Therapeutics' Other Operating Expenses tumbled by 93.18% in 2022, and later climbed by 7.65% in 2024.
  • Over the past 4 years, Whitehawk Therapeutics' Other Operating Expenses (Yearly) stood at $74.2 million in 2021, then slumped by 93.18% to $5.1 million in 2022, then tumbled by 44.48% to $2.8 million in 2023, then rose by 7.65% to $3.0 million in 2024.